1. Home
  2. CGEN vs ACU Comparison

CGEN vs ACU Comparison

Compare CGEN & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • ACU
  • Stock Information
  • Founded
  • CGEN 1993
  • ACU 1867
  • Country
  • CGEN Israel
  • ACU United States
  • Employees
  • CGEN N/A
  • ACU N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • ACU Industrial Machinery/Components
  • Sector
  • CGEN Health Care
  • ACU Consumer Discretionary
  • Exchange
  • CGEN Nasdaq
  • ACU Nasdaq
  • Market Cap
  • CGEN 125.3M
  • ACU 145.9M
  • IPO Year
  • CGEN 2000
  • ACU N/A
  • Fundamental
  • Price
  • CGEN $1.95
  • ACU $38.19
  • Analyst Decision
  • CGEN
  • ACU
  • Analyst Count
  • CGEN 0
  • ACU 0
  • Target Price
  • CGEN N/A
  • ACU N/A
  • AVG Volume (30 Days)
  • CGEN 560.3K
  • ACU 11.8K
  • Earning Date
  • CGEN 11-11-2025
  • ACU 10-21-2025
  • Dividend Yield
  • CGEN N/A
  • ACU 1.67%
  • EPS Growth
  • CGEN N/A
  • ACU N/A
  • EPS
  • CGEN N/A
  • ACU 2.55
  • Revenue
  • CGEN $22,144,000.00
  • ACU $194,061,991.00
  • Revenue This Year
  • CGEN N/A
  • ACU $2.85
  • Revenue Next Year
  • CGEN $208.08
  • ACU $4.16
  • P/E Ratio
  • CGEN N/A
  • ACU $15.06
  • Revenue Growth
  • CGEN N/A
  • ACU 0.70
  • 52 Week Low
  • CGEN $1.13
  • ACU $34.35
  • 52 Week High
  • CGEN $2.66
  • ACU $45.42
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 60.17
  • ACU 35.09
  • Support Level
  • CGEN $1.30
  • ACU $37.81
  • Resistance Level
  • CGEN $2.38
  • ACU $38.85
  • Average True Range (ATR)
  • CGEN 0.17
  • ACU 1.00
  • MACD
  • CGEN 0.04
  • ACU -0.21
  • Stochastic Oscillator
  • CGEN 57.00
  • ACU 10.82

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

Share on Social Networks: